1. Home
  2. LEXX vs KFFB Comparison

LEXX vs KFFB Comparison

Compare LEXX & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • KFFB
  • Stock Information
  • Founded
  • LEXX 2004
  • KFFB 2005
  • Country
  • LEXX Canada
  • KFFB United States
  • Employees
  • LEXX N/A
  • KFFB N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • KFFB Savings Institutions
  • Sector
  • LEXX Health Care
  • KFFB Finance
  • Exchange
  • LEXX Nasdaq
  • KFFB Nasdaq
  • Market Cap
  • LEXX 19.6M
  • KFFB 21.0M
  • IPO Year
  • LEXX N/A
  • KFFB 2005
  • Fundamental
  • Price
  • LEXX $0.89
  • KFFB $2.91
  • Analyst Decision
  • LEXX Strong Buy
  • KFFB
  • Analyst Count
  • LEXX 1
  • KFFB 0
  • Target Price
  • LEXX $5.00
  • KFFB N/A
  • AVG Volume (30 Days)
  • LEXX 146.9K
  • KFFB 6.2K
  • Earning Date
  • LEXX 07-22-2025
  • KFFB 05-12-2025
  • Dividend Yield
  • LEXX N/A
  • KFFB N/A
  • EPS Growth
  • LEXX N/A
  • KFFB N/A
  • EPS
  • LEXX N/A
  • KFFB N/A
  • Revenue
  • LEXX $525,923.00
  • KFFB $8,308,000.00
  • Revenue This Year
  • LEXX $0.62
  • KFFB N/A
  • Revenue Next Year
  • LEXX $14.19
  • KFFB N/A
  • P/E Ratio
  • LEXX N/A
  • KFFB N/A
  • Revenue Growth
  • LEXX 29.95
  • KFFB 13.79
  • 52 Week Low
  • LEXX $0.82
  • KFFB $1.96
  • 52 Week High
  • LEXX $4.38
  • KFFB $3.62
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 41.23
  • KFFB 69.42
  • Support Level
  • LEXX $0.86
  • KFFB $2.90
  • Resistance Level
  • LEXX $1.05
  • KFFB $3.00
  • Average True Range (ATR)
  • LEXX 0.06
  • KFFB 0.09
  • MACD
  • LEXX 0.00
  • KFFB 0.03
  • Stochastic Oscillator
  • LEXX 30.70
  • KFFB 86.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About KFFB Kentucky First Federal Bancorp

Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.

Share on Social Networks: